Safety and immunogenicity of a prototype oral whole-cell killed Campylobacter vaccine administered with a mucosal adjuvant in non-human primates

By Baqar S.   Bourgeois A.L.   Schultheiss P.J.   Walker R.I.   Rollins D.M.   Haberberger R.L.   Pavlovskis O.R.  

Vaccine, Vol. 13, Iss. 1, 1995-01 ,pp. : 22-28

Elsevier

Access to resources Recommend Favorite

Estimates of the effectiveness of a whole-cell pertussis vaccine from an outbreak in an immunized population

By Bentsi-Enchill A.D.   Halperin S.A.   Scott J.   MacIsaac K.   Duclos P.  

Vaccine, Vol. 15, Iss. 3, 1997-02 ,pp. : 301-306

Elsevier

Access to resources Recommend Favorite

Vaccination with whole-cell vaccine and bacterial protein extract protects tilapia against Streptococcus difficile meningoencephalitis

By Eldar A.   Shapiro O.   Bejerano Y.   Bercovier H.  

Vaccine, Vol. 13, Iss. 9, 1995-06 ,pp. : 867-870

Elsevier

Access to resources Recommend Favorite

Induction of antigen-specific T cell responses in human volunteers after intranasal immunization with a whole-cell pertussis vaccine

By Berstad A.K.H.   Oftung F.   Korsvold G.E.   Haugen I.L.   Froholm L.O.   Holst J.   Haneberg B.  

Vaccine, Vol. 18, Iss. 22, 2000-05 ,pp. : 2323-2330

Elsevier

Access to resources Recommend Favorite

Evaluation of a combined tetravalent diphtheria, tetanus, whole-cell pertussis and hepatitis B candidate vaccine administered to healthy infants according to a three-dose vaccination schedule

By Papaevangelou G.   Karvelis E.   Alexiou D.   Kiossoglou K.   Roumeliotou A.   Safary A.   Collard F.   Vandepapeliere P.  

Vaccine, Vol. 13, Iss. 2, 1995-02 ,pp. : 175-178

Elsevier

Access to resources Recommend Favorite